Fixed drug eruption after Pfizer-BioNTech COVID-19 vaccine: A case report.

Lellig, Elodie; Mouton-Faivre, Claudie; Abs, Diane; Bursztejn, Anne-Claire

Lellig, Elodie; Mouton-Faivre, Claudie; Abs, Diane; Bursztejn, Anne-Claire.

Lellig E; Department of Dermatology and Allergology, University Hospital of Nancy, VandÅuvre-lès-Nancy, France.
Mouton-Faivre C; Department of Dermatology and Allergology, University Hospital of Nancy, VandÅuvre-lès-Nancy, France.
Abs D; Department of Dermatology and Allergology, University Hospital of Nancy, VandÅuvre-lès-Nancy, France.
Bursztejn AC; Department of Dermatology and Allergology, University Hospital of Nancy, VandÅuvre-lès-Nancy, France. Electronic address: ac.bursztejn@chru-nancy.fr.

J Allergy Clin Immunol Pract ; 10(7): 1922-1923, 2022 07.

Article in English | MEDLINE | ID: covidwho-1799880

Subject(s)

COVID-19; Drug Eruptions; BNT162 Vaccine; Drug Eruptions/diagnosis; Drug Eruptions/etiology; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Drug Eruptions / COVID-19 Type of study: Case report / Diagnostic study Topics: Vaccines Limits: Humans Language: English Journal: J Allergy Clin Immunol Pract Year: 2022 Document Type: Article Affiliation country: J.jaip.2022.03.033

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google